Age and disability accumulation in multiple sclerosis

被引:198
|
作者
Scalfari, A. [1 ]
Neuhaus, A. [2 ]
Daumer, M. [2 ]
Ebers, G. C. [3 ]
Muraro, P. A. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Ctr Neurosci, Div Expt Med, London, England
[2] Sylvia Lawry Ctr, Munich, Germany
[3] Univ Oxford, Dept Neurol, Oxford, England
基金
英国医学研究理事会;
关键词
NATURAL-HISTORY; PROGNOSTIC-FACTORS; CLINICAL-COURSE; PROGRESSION; PREDICTORS; RELAPSES;
D O I
10.1212/WNL.0b013e318230a17d
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: We tested the hypothesis that age is a prognostic factor with respect to long-term accumulation of disability in multiple sclerosis (MS). Methods: Kaplan-Meier analysis and binary logistic regression models determined the effect of age at disease onset, age at onset of progression, and current age on attainment of severe disability levels (Disability Status Scale [DSS] 6-8-10) from the London, Ontario, database (n = 1,023). Results: Older age at relapsing-remitting (RR) phase onset was associated with higher risk of reaching advanced DSS scores. This was independent of disease duration and early relapse frequency but secondary to increased risk of conversion to secondary progressive (SP) MS. Onset at age 40 (odds ratio [OR] = 4.22) and at age 50 (OR = 6.04) doubled and tripled risks of developing SP, compared to age 20 (OR = 2.05). Younger age at conversion to SPMS was associated with shorter times to high DSS scores from disease onset. The progressive course, unaffected by age at RR onset, was only modestly affected by age at SP onset. Among primary progressive and RR/SP patients, median ages at attainment of DSS scores were strikingly similar: DSS = 6, 49 vs 48 years; DSS = 8, 58 vs 58 years; and DSS = 10, 78 years for both (p = NS for all comparisons). Conclusions: Development of SP is the dominant determinant of long-term prognosis, independent of disease duration and early relapse frequency. Age independently affects disability development primarily by changing probability and latency of SP onset, with little effect on the progressive course. Neurology (R) 2011; 77: 1246-1252
引用
收藏
页码:1246 / 1252
页数:7
相关论文
共 50 条
  • [21] Sodium accumulation is associated with disability and a progressive course in multiple sclerosis
    Paling, David
    Solanky, Bhavana S.
    Riemer, Frank
    Tozer, Daniel J.
    Wheeler-Kingshott, Claudia A. M.
    Kapoor, Raju
    Golay, Xavier
    Miller, David H.
    [J]. BRAIN, 2013, 136 : 2305 - 2317
  • [22] Association Between Alcohol Consumption and Disability Accumulation in Multiple Sclerosis
    Wu, Jing
    Olsson, Tomas
    Hillert, Jan A.
    Alfredsson, Lars
    Hedstroem, Anna Karin
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (05):
  • [23] Reply to: Age at disability milestones in multiple sclerosis and history of multiple sclerosis: a unifying concept
    Confavreux, Christian
    Vukusic, Sandra
    [J]. BRAIN, 2006, 129
  • [24] Age Related Multiple Sclerosis Severity Score: Disability ranked by age
    Manouchehrinia, Ali
    Westerlind, Helga
    Kingwell, Elaine
    Zhu, Feng
    Carruthers, Robert
    Ramanujam, Ryan
    Ban, Maria
    Glaser, Anna
    Sawcer, Stephen
    Tremlett, Helen
    Hillert, Jan
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (14) : 1938 - 1946
  • [25] Age Related Multiple Sclerosis Severity Score: Disability Ranked by Age
    Manouchehrinia, Ali
    Helga, Westerlind
    Kingwell, Elaine
    Zhu, Feng
    Carruthers, Robert
    Ujam, Ryan Raman
    Maria, Ban
    Glaser, Anna
    Sawcer, Stephen
    Tremlett, Helen
    Hillert, Jan
    [J]. NEUROLOGY, 2016, 86
  • [26] Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis
    Usta, Nuray Can
    Boz, Cavit
    Terzi, Murat
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 224
  • [27] Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosis
    Magyari, Melinda
    Koch-Henriksen, Nils
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (07): : 716 - 722
  • [28] Predicting Tempo of Post-Progression Disability Accumulation in Multiple Sclerosis
    Soldan, M. Paz
    Tutuncu, Melih
    Tang, Junger
    Abou Zeid, Nuhad
    Kale, Nilufer
    Crusan, Daniel
    Atkinson, Elizabeth
    Siva, Aksel
    Pittock, Sean
    Pirko, Istvan
    Keegan, Mark
    Lucchinetti, Claudia
    Noseworthy, John
    Rodriguez, Moses
    Weinshenker, Brian
    Kantarci, Orhun
    [J]. NEUROLOGY, 2013, 80
  • [29] Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis
    Lizak, Nathaniel S.
    Lugaresi, Alessandra
    Alroughani, Raed
    Lechner-Scott, Jeanette
    Slee, Mark
    Jokubaitis, Vilija
    Spelman, Tim
    Butzkueven, Helmut
    Kalincik, Tomas
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 2 - 2
  • [30] Immunomodulatory therapy slows accumulation of disability in moderately advanced multiple sclerosis
    Lizak, N.
    Lugaresi, A.
    Alroughani, R.
    Lechner-Scott, J.
    Slee, M.
    Havrdova, E.
    Horakova, D.
    Trojano, M.
    Izquierdo, G.
    Duquette, P.
    Girard, M.
    Prat, A.
    Grammond, P.
    Hupperts, R.
    Sola, P.
    Grand'Maison, F.
    Bergamaschi, R.
    Pucci, E.
    Oreja-Guevara, C.
    Cabrera-Gomez, J. A.
    Van Pesch, V.
    Petersen, T.
    Boz, C.
    Ramo, C.
    Rio, M. E.
    Iuliano, G.
    Fernandez-Bolanos, R.
    Granella, F.
    Spitaleri, D. L. A.
    Verheul, F.
    Terzi, M.
    Rozsa, C.
    Amato, M. P.
    Olascoaga, J.
    Flechter, S.
    Cristiano, E.
    Rojas, J. I.
    Hodgkinson, S.
    Jokubaitis, V.
    Spelman, T.
    Butzkueven, H.
    Kalincik, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 308 - 310